Onco4D clinical trial results announced at the ASCO annual meeting: 97% negative predictive value for pathologic complete response to chemotherapy in breast cancer patients.
Onco4D clinical trial results announced at the ASCO annual meeting: 97% negative predictive value for pathologic complete response to chemotherapy in breast cancer patients.
